Advances in the roles and mechanisms of mesenchymal stem cell derived microRNAs on periodontal tissue regeneration Authors: Jiaxiang Zhang, Liangrui Chen, Jialu Yu, Weidong Tian, Shujuan Guo Published: 2024 ABSTRACT Periodontitis is one of the most prevalent oral diseases leading to tooth loss in adults, and is characterized by the destruction of periodontal supporting structures. Traditional therapies for periodontitis cannot achieve ideal regeneration of the periodontal tissue. Mesenchymal stem cells (MSCs) represent a promising approach to periodontal tissue regeneration. Recently, the prominent role of MSCs in this context has been attributed to microRNAs (miRNAs), which participate in post-transcriptional regulation and are crucial for various physiological and pathological processes. Additionally, they function as indispensable elements in extracellular vesicles, which protect them from degradation. In periodontitis, MSCs-derived miRNAs play a pivotal role in cellular proliferation and differentiation, angiogenesis of periodontal tissues, regulating autophagy, providing anti-apoptotic effects, and mediating the inflammatory microenvironment. As a cell-free strategy, their small size and ability to target related sets of genes and regulate signaling networks predispose miRNAs to become ideal candidates for periodontal tissue regeneration. This review aims to introduce and summarize the potential functions and mechanisms of MSCs-derived miRNAs in periodontal tissue repair and regeneration.Graphical Abstract Introduction Periodontitis is primarily a chronic infectious disease of periodontal tissues caused by plaque biofilm and is a risk factor for various systemic diseases, such as diabetes mellitus, cardiovascular complications, Alzheimer’s disease, tumors, etc [1]. (Fig. 1). Fig. 1Schematics of systemic diseases that are closely related to periodontitis Schematics of systemic diseases that are closely related to periodontitis Conventional treatment strategies fail to achieve periodontal support structure regeneration [2]. Recent insights into cell-based therapeutics may play an important role in the realization of robust and efficient periodontal regeneration [3]. Mesenchymal stem cells (MSCs) have emerged as the most extensively researched and applied stem cells in regenerative medicine [4]. Their therapeutic potential can be attributed to cell homing, promotion of cell differentiation, and secretion of bioactive factors [5, 6]. Actually, most of the stem cells which transmigrate to the focus of injury were sacrificed due to limited homing and poor survival [7]. Recent studies have brought attention to the wide array of bioactive components of MSCs [8]. In this process, microRNAs (miRNAs) constitute an important fraction of MSCs content have attracted much attention for its potential use in tissue repair and regeneration [9, 10]. MiRNAs are small non-coding RNAs that regulate gene expression [11] by binding to complementary sites on target genes and mediating post-transcriptional gene silencing [12]. Interestingly, the expression of miRNAs in cells are specific, and their changes in response to fluctuations in physiological states or pathological conditions [13–15]. In addition, miRNAs encapsulated in MSCs-secreted exosomes, acting as mediators of intercellular signaling, regulating effector cell functions, and ameliorating inflammatory reactions [16]. Both miRNAs may be capable of independently triggering regeneration and repair, as well as encouraging angiogenesis and cell proliferation, regulating autophagy, and reducing apoptosis, while mediating inflammation in periodontitis [17–20]. In recent years, substantial studies found the relationship between MSCs-derived miRNAs and periodontitis, yet there is considerable heterogeneity among the studied miRNAs. The objective of this review was to identify and summarize a set of microRNAs which express specifically in MSCs can be used as targets in periodontal diseases, to refine the expression patterns with respect to specific cell and to examine their roles in mechanistic studies, and to determine which of them show the precise therapeutic performance for periodontal regeneration. Mesenchymal stem cell-derived miRNAs in periodontal tissue regeneration We observed that miRNAs are versatile and stable, capable of existing as either intracellular or extracellular entities [21], which can be found partly encapsulated in MSCs-secreted exosomes [22]. The sources, expression levels, regulatory functions, and mechanisms of action show significant differences between these two forms: [23] exosomal miRNAs which are released from cells into microenvironment are generally less concentrated than their intracellular counterparts, and current high-throughput sequencing technologies are able to detect these variations [24, 25] (Fig. 2). Fig. 2Multi-omics approaches to predict differentially expressed miRNAs and their downstream targets Multi-omics approaches to predict differentially expressed miRNAs and their downstream targets However, little is known about how and what determines the miRNA content of extracellular vesicles (EVs) from MSCs, which is a critical issue for further therapeutic applications [26].Furthermore, MSCs-derived exosomes provide considerable stability to the miRNAs they carry, protecting them from enzymatic degradation and facilitating delivery to recipient cells through various pathways [27]. Additionally, while intracellular miRNAs are produced through their own transcription and processing [28], miRNAs in exosomes primarily originate from the secretion and release of intracellular miRNAs [29]. Importantly, the regulatory effects of miRNAs are heavily influenced by their cellular location. Endogenous miRNAs regulate intracellular gene expression and influence the physiopathological activities of the cells in which they are located [30]. Conversely, exosomal miRNAs do not degrade after delivery into cells and can act as cellular messengers to impact a more diverse set of recipient cells [31]. Intracellular miRNAs within MSCs Intracellular miRNAs are produced by two RNase III proteins, Drosha and Dicer [32]. In the following sections, we briefly discuss a few selective and prevalent miRNAs within MSCs [33]. (Table 1). Importantly, we focus primarily on functions of these miRNAs associated with periodontal regeneration that were shown to be differentially expressed in MSCs in the recent studies (Fig. 3). Table 1Intracellular miRNAs from MSCs in periodontal regenerationmiRNAsMSC typeExpressionTarget MechanismsFunctional effectsRefs. and yearmiR-31BMSCsUp-regulatedSuppresses the levels of OsterixRegulates osteogenic differentiation and mineralization of BMSCsBAGLIO et al. [35], 2013miR-21HUCBMSCsUp-regulatedTargets carboxyl terminus of Hsc70-interacting protein (CHIP)Promotes angiogenesisZHOU et al. [41], 2016PDLSCsDown-regulatedTargets Smad5 and stimulates the Smad5-Runx2 signaling pathwayInhibits osteogenic differentiationWEI et al. [42], 2017BMSCsUp-regulatedVia the PTEN/PI3K/Akt/HIF-1α pathwayEnhanced osteogenic differentiationYANG et al. [43], 2019miR-214PDLSCsDown-regulatedDirectly targets the βcatenin gene CTNNB1, and suppresses Wnt/βcatenin signalingPromotes osteoblastic differentiationCAO et al. [44], 2017miR-22PDLSCsUp-regulatedInhibits Histone deacetylase6(HDAC6) expressionPromotes the osteogenic differentiation of PDLSCsYAN et al. [45], 2017miR-543PDLSCsUp-regulatedInhibits the expression of transducer of ERBB2, 2 (TOB2)Enhances osteogenic differentiation of PDLSCsGE et al. [46], 2018miR-210PDLSCsUp-regulatedRegulates angiogenesis related to VEGF expression,Stimulates osteogenesis and angiogenesisPIZZICANNELLA et al. [47], 2018miR-125bPDLSCsDown-regulatedInhibits NF-κB inhibitor interacting RAS-like 2 (NKIRAS2) /NF-κB pathwayParticipates in osteogenic differentiation of PDLSCsXUE et al. [48], 2018miR-200cBMSCsUp-regulatedEffectively downregulates IL-8, IL‐6 and chemokine (C‐C motif) ligand (CCL)‐5 by targeting their 3’UTRs,Participates in osteogenic differentiation of BMSCsAKKOUCH et al. [49], 2019miR-23aPDLSCsUp-regulatedTargets BMPR1B, which leads to the reduced phosphorylation of Smad1/5/9 and BMP signalingInhibits osteogenesis of PDLSCsZHANG et al. [50], 2019miR-132PDLSCsDown-regulatedBinds to growth differentiation factor 5 (GDF5) and regulates NF-κB signaling pathwayInhibits osteogenesis of PDLSCsXU et al. [38], 2019miR-24-3pPDLSCsDown-regulatedTargets SMAD family member 5 (Smad5),Promotes osteogenic differentiation of PDLSCsLI et at. [51], 2019miR-153-3pPDLSCsDown-regulatedTargets Lysine demethylase 6 A (KDM6A)Promotes the osteogenic differentiation of PDLSCsIANG et al. [52], 2021miR-23bPDLSCsUp-regulatedReduces the expression of runt-related transcription factor 2 (Runx2)Suppresses the osteogenic differentiation of PDLSCsSUN et al. [53], 2021miR-184PDLSCsDown-regulatedTargets NFI-C (nuclear factor I-C)Promotes osteoblastic differentiationLI et al. [54], 2021miR-383-5pPDLSCsUp-regulatedSuppresses histone deacetylase (HDAC) 9Facilitates the osteogenic differentiation of PDLSCsMA et al. [55], 2021miR-589-3pPDLSCsUp-regulatedDirectly targets Activating Transcription Factor 1(ATF1)Enhances the osteogenic capacity of PDLSCsSHI et al. [39], 2022miR-223PDL-derived cellsDown-regulatedSuppresses of fibroblast growth factor receptor 2 (FGFR2) and transforming growth factor beta receptor 2 (TGFβR2)Promotes PDL-derived cells osteogenesisZHANG et al. [13], 2022miR-200a-3pPDLSCsDown-regulatedTargets ZEB2 and activates the NF-κB pathwayRepresses osteogenesisWANG et al. [56], 2022miR-142-3pPDLSCsDown-regulatedInhibits SKG1 expressionRegulates osteogenic differentiationSUN et al. [57], 2023miR-30aPDLSCsUp-regulatedActivates the wnt/β-catenin signaling pathway to enhance the expression of CTSKPromotes PDLSCs to form cementum-like tissuesLIU et al. [58], 2021miR-628-5phMSCsUp-regulatedInhibits ETV1, GATA6, and SOX11Negatively regulates MSC stemness during periodontal regenerationIWATA et al. [59], 2017miR-146aPDLSCsUp-regulatedDownregulates IL-17 and IL-35 expressionInhibits proliferation of human PDLSCs.ZHAO et al. [60], 2019miR-375PDLSCsUp-regulatedTargets transducer of ERBB2, 2 (TOB2)Facilitates the proliferation and osteogenic differentiation of PDLSCsWANG et al. [61], 2020miR-28-5pPDLSCsDown-regulatedSuppresses sphingosine kinase − 1 (SPHK1)Inhibits cell proliferation and promotes inflammationHUANG et al. [62], 2022miR-200a-3pBMSCsUp-regulatedDownregulates its target Forkhead Box Protein J1Contributes to BMSCs migrationLI et al. [24], 2020miR-128-3pBMSCsUp-regulatedTargets sirtuin 1Exacerbates the TNF-α-induced inflammatory responseWU et al. [63], 2020miR-212-5pPDLSCsDown-regulatedInhibits myeloid differentiation factor 88 (Myd88)Regulates the inflammatory response of PDLSCsHUA et al. [64], 2020miR-20amiR-30emiR-93GMSCsUp-regulatedDown-regulatedDown-regulatedDecreases the expression of the nuclear factor of activated T cells-5(NFAT5)Relates to GMSCs under hypoxic and inflammatory conditionsCHAPARRO et al. [65], 2022miR-203PDLSCsDown-regulatedDownregulates AP-1/ICAM-1 axisInhibits PDLSCs differentiation and promotes inflammatory responsesYANG et al. [66], 2023miR-671-5pPDLSCsUp-regulatedTargets DUSP8/p38 MAPK pathwayDecreases cell viability, and increases the expression of inflammatory factorsWANG et al. [67], 2024miR-152-3pPDLSCsDown-regulatedSilences integrin alpha 5 (ITGA5)Promotes PDLSCs viability and osteogenic differentiationWU et al. [68], 2020 Table 1Intracellular miRNAs from MSCs in periodontal regenerationmiRNAsMSC typeExpressionTarget MechanismsFunctional effectsRefs. and yearmiR-31BMSCsUp-regulatedSuppresses the levels of OsterixRegulates osteogenic differentiation and mineralization of BMSCsBAGLIO et al. [35], 2013miR-21HUCBMSCsUp-regulatedTargets carboxyl terminus of Hsc70-interacting protein (CHIP)Promotes angiogenesisZHOU et al. [41], 2016PDLSCsDown-regulatedTargets Smad5 and stimulates the Smad5-Runx2 signaling pathwayInhibits osteogenic differentiationWEI et al. [42], 2017BMSCsUp-regulatedVia the PTEN/PI3K/Akt/HIF-1α pathwayEnhanced osteogenic differentiationYANG et al. [43], 2019miR-214PDLSCsDown-regulatedDirectly targets the βcatenin gene CTNNB1, and suppresses Wnt/βcatenin signalingPromotes osteoblastic differentiationCAO et al. [44], 2017miR-22PDLSCsUp-regulatedInhibits Histone deacetylase6(HDAC6) expressionPromotes the osteogenic differentiation of PDLSCsYAN et al. [45], 2017miR-543PDLSCsUp-regulatedInhibits the expression of transducer of ERBB2, 2 (TOB2)Enhances osteogenic differentiation of PDLSCsGE et al. [46], 2018miR-210PDLSCsUp-regulatedRegulates angiogenesis related to VEGF expression,Stimulates osteogenesis and angiogenesisPIZZICANNELLA et al. [47], 2018miR-125bPDLSCsDown-regulatedInhibits NF-κB inhibitor interacting RAS-like 2 (NKIRAS2) /NF-κB pathwayParticipates in osteogenic differentiation of PDLSCsXUE et al. [48], 2018miR-200cBMSCsUp-regulatedEffectively downregulates IL-8, IL‐6 and chemokine (C‐C motif) ligand (CCL)‐5 by targeting their 3’UTRs,Participates in osteogenic differentiation of BMSCsAKKOUCH et al. [49], 2019miR-23aPDLSCsUp-regulatedTargets BMPR1B, which leads to the reduced phosphorylation of Smad1/5/9 and BMP signalingInhibits osteogenesis of PDLSCsZHANG et al. [50], 2019miR-132PDLSCsDown-regulatedBinds to growth differentiation factor 5 (GDF5) and regulates NF-κB signaling pathwayInhibits osteogenesis of PDLSCsXU et al. [38], 2019miR-24-3pPDLSCsDown-regulatedTargets SMAD family member 5 (Smad5),Promotes osteogenic differentiation of PDLSCsLI et at. [51], 2019miR-153-3pPDLSCsDown-regulatedTargets Lysine demethylase 6 A (KDM6A)Promotes the osteogenic differentiation of PDLSCsIANG et al. [52], 2021miR-23bPDLSCsUp-regulatedReduces the expression of runt-related transcription factor 2 (Runx2)Suppresses the osteogenic differentiation of PDLSCsSUN et al. [53], 2021miR-184PDLSCsDown-regulatedTargets NFI-C (nuclear factor I-C)Promotes osteoblastic differentiationLI et al. [54], 2021miR-383-5pPDLSCsUp-regulatedSuppresses histone deacetylase (HDAC) 9Facilitates the osteogenic differentiation of PDLSCsMA et al. [55], 2021miR-589-3pPDLSCsUp-regulatedDirectly targets Activating Transcription Factor 1(ATF1)Enhances the osteogenic capacity of PDLSCsSHI et al. [39], 2022miR-223PDL-derived cellsDown-regulatedSuppresses of fibroblast growth factor receptor 2 (FGFR2) and transforming growth factor beta receptor 2 (TGFβR2)Promotes PDL-derived cells osteogenesisZHANG et al. [13], 2022miR-200a-3pPDLSCsDown-regulatedTargets ZEB2 and activates the NF-κB pathwayRepresses osteogenesisWANG et al. [56], 2022miR-142-3pPDLSCsDown-regulatedInhibits SKG1 expressionRegulates osteogenic differentiationSUN et al. [57], 2023miR-30aPDLSCsUp-regulatedActivates the wnt/β-catenin signaling pathway to enhance the expression of CTSKPromotes PDLSCs to form cementum-like tissuesLIU et al. [58], 2021miR-628-5phMSCsUp-regulatedInhibits ETV1, GATA6, and SOX11Negatively regulates MSC stemness during periodontal regenerationIWATA et al. [59], 2017miR-146aPDLSCsUp-regulatedDownregulates IL-17 and IL-35 expressionInhibits proliferation of human PDLSCs.ZHAO et al. [60], 2019miR-375PDLSCsUp-regulatedTargets transducer of ERBB2, 2 (TOB2)Facilitates the proliferation and osteogenic differentiation of PDLSCsWANG et al. [61], 2020miR-28-5pPDLSCsDown-regulatedSuppresses sphingosine kinase − 1 (SPHK1)Inhibits cell proliferation and promotes inflammationHUANG et al. [62], 2022miR-200a-3pBMSCsUp-regulatedDownregulates its target Forkhead Box Protein J1Contributes to BMSCs migrationLI et al. [24], 2020miR-128-3pBMSCsUp-regulatedTargets sirtuin 1Exacerbates the TNF-α-induced inflammatory responseWU et al. [63], 2020miR-212-5pPDLSCsDown-regulatedInhibits myeloid differentiation factor 88 (Myd88)Regulates the inflammatory response of PDLSCsHUA et al. [64], 2020miR-20amiR-30emiR-93GMSCsUp-regulatedDown-regulatedDown-regulatedDecreases the expression of the nuclear factor of activated T cells-5(NFAT5)Relates to GMSCs under hypoxic and inflammatory conditionsCHAPARRO et al. [65], 2022miR-203PDLSCsDown-regulatedDownregulates AP-1/ICAM-1 axisInhibits PDLSCs differentiation and promotes inflammatory responsesYANG et al. [66], 2023miR-671-5pPDLSCsUp-regulatedTargets DUSP8/p38 MAPK pathwayDecreases cell viability, and increases the expression of inflammatory factorsWANG et al. [67], 2024miR-152-3pPDLSCsDown-regulatedSilences integrin alpha 5 (ITGA5)Promotes PDLSCs viability and osteogenic differentiationWU et al. [68], 2020 Intracellular miRNAs from MSCs in periodontal regeneration miR-20a miR-30e miR-93 Up-regulated Down-regulated Down-regulated Fig. 3Schematics of mechanisms that MSCs-derived miRNAs promote periodontal regeneration on cell migration and differentiation, angiogenesis of periodontal tissues, regulating autophagy and anti-apoptotic anti-inflammatory. A. MiRNAs suppress inflammatory cell migration to the injury site and promote repairable cell proliferation and differentiation. b. MiRNAs promote bone regeneration by interacting with target cells, including osteoblasts and osteoclasts. c. Angiogenesis is also closely associated with regeneration. D. MiRNAs control pro-inflammatory and anti-inflammatory responses in the periodontal microenvironment. E. MiRNAs regulate autophagy and apoptosis Schematics of mechanisms that MSCs-derived miRNAs promote periodontal regeneration on cell migration and differentiation, angiogenesis of periodontal tissues, regulating autophagy and anti-apoptotic anti-inflammatory. A. MiRNAs suppress inflammatory cell migration to the injury site and promote repairable cell proliferation and differentiation. b. MiRNAs promote bone regeneration by interacting with target cells, including osteoblasts and osteoclasts. c. Angiogenesis is also closely associated with regeneration. D. MiRNAs control pro-inflammatory and anti-inflammatory responses in the periodontal microenvironment. E. MiRNAs regulate autophagy and apoptosis MiR-31 exerts a regulatory influence on the osteogenic differentiation of MSCs. MiR-31 and Osterix inversely correlate during osteogenic differentiation. The expression of miR-31 in bone marrow stem cells (BMSCs) increases interacting with the Osterix (SP7), bone-specific transcription factor, which is essential for controlling osteoblast maturation and bone formation [34]. Suppression of Osterix levels enhances alkaline phosphatase activity and the deposition of mineralized nodules, demonstrating the role of miR-31 in the regulation of osteogenic differentiation and mineralization of bone marrow stem cells (BMSCs) [35]. Moreover, miR-31 expression is significantly lower in periodontitis gingival tissue compared to healthy gingival, which can result in suppression of osteogenesis process and the progression of bone resorption [36]. MiR-132 is downregulated during the osteogenic differentiation of Periodontal ligament stem cells (PDLSCs), which are pivotal in maintaining the stability of the periodontal ligament, repairing osteochondral tissue damage, and enhancing cellular renewal and function, rendering them ideal for periodontal tissue regeneration [37].In other words, miR-132 overexpression inhibits PDLSCs osteogenesis. Xu et al. found that the mRNA and protein levels of ALP, BMP2, Runx2, and OCN in PDLSCs decreased substantially by targeting growth differentiation factor 5(GDF5) and activating the NF-κB axis. The intersection of miR-132, GDF5, and NF-κB regulates osteogenic differentiation of PLDSCs [38]. MiR-589-3p was identified as the most upregulated miRNA in osteogenic induction and non-induction of PDLSCs. The expression of miR-583-3p was notably increased in PDLSCs during osteogenic induction, enhancing the osteogenic capacity of PDLSCs along with increases in ALP activity, matrix mineralization, and RUNX2, OCN, and OSX expression. Bioinformatics analysis and luciferase activity assays showed that miR-589-3p directly targeted ATF1 to promote the proliferation and osteogenic differentiation of PDLSCs [39]. MiR-21 has been previously reported to be highly expressed in many tumor cells, associated with tumor progression [40]. Recently several studies have highlighted is also predominantly found in mesenchymal stem cells and plays a crucial role in tissue regeneration: miR-21 overexpression in human umbilical cord blood-derived mesenchymal stem cells (HUCBMSCs) promotes angiogenesis by enhancing hypoxia-inducible factor-1α (HIF-1α) activity [41]. Additionally, rising miR-21 can markedly enhanced osteogenic differentiation in bone marrow stem cells (BMSCs) via the PTEN/PI3K/Akt/HIF-1α pathway [43]. During osteogenic differentiation of PDLSCs, the expression level of miR-21 is reduced. Molecular mechanism has shown that it targets to Smad5 and stimulates the Smad5-Runx2 signaling pathway, suppresses the expression of osteogenic-related genes, and inhibits osteogenic differentiation in PDLSCs miR-21 [42].Therefore, these studies investigated the function of miR-21 in MSCs, which could provide clues to increase our understanding of altering the expression of intracellular miRNAs in various cells or control several gene regulatory networks may have opposite effects on periodontal tissue regeneration [69]. Furthermore, the expression and regulatory functions of miRNAs differ under various environmental conditions: miR-21 is expressed at elevated levels in mechanically stretched PDLSCs compared to untreated cells. In vitro, mechanical force-induced stimulation alters bone remodeling homeostasis, and miR-21 directly regulates ACVR2B—a key regulator of osteogenic differentiation—thereby enhancing osteogenic differentiation in stretched PDLSCs [70]. Wu et al. reported that miR-21 also modulates the immune microenvironment and influences MSCs regeneration by downregulating transforming growth factor-β1 (TGF-β1) [71]. Cytokine stimulation leads to significant alterations in the expression profiles of miRNAs and transcription factors in mesenchymal stem cells [72]. Research has shown that periodontal regenerative cytokines treatment such as FGF2, BDNF, BMP2 suppresses the expression of miR-628-5p in Human MSCs (HMSCs), highlighting miR-628-5p as a key miRNA in the periodontal regeneration process. MiR-628-5p adversely affects the stemness of MSCs relevant to periodontal regeneration. Specifically, miR-628-5p facilitates the osteogenic process in MSCs by suppressing the upregulation of ETV1, GATA6, and SOX11, thereby enhancing periodontal regeneration. Overexpression of miR-628-5p also influences the expression of related transcription factors and reduces the proliferative capacity of tissue cells [59]. Extracellular miRNAs within exosomes The role of stem cells in tissue regeneration does not depend completely on direct proliferation and differentiation of MSCs at the site of injury, but also plays an important role in paracrine action, in which bioactive substances can diffuse to neighboring cells through the intercellular space, participate in cell-to-cell communication, and affect the biological functions of tissue cells [73]. Therefore, exosomes are extracellular vesicles secreted by MSCs which carries bioactive molecules including proteins, nucleic acids, and lipids, being envisioned as a new and attractive source of MSCs for tissue engineering [74] (Fig. 4). Fig. 4The biogenesis and components of extracellular vesicles (EVs) in MSCs The biogenesis and components of extracellular vesicles (EVs) in MSCs As a key component of MSCs-EVs, miRNAs are shown to have promising regenerative properties to periodontitis [75]. Consequently, several studies have been described miRNAs highly enriched in exosomes to explore the potential effect and mechanisms of exosomal miRNAs (Table 2), functions of these miRNAs will be specifically submitted below. Table 2Specific miRNAs in MSCs-EVs with reported roles in periodontal regenerationmiRNAsEVs sourceTarget MechanismsFunctional effectsRefs. and yearmiR-22-3pBMSCsNegatively targeted FTO expressionPromotes osteogenic differentiationZHANG et al. [77], 2020miR-335-5pBMSCsDownregulates the expression of DKK1Promotes osteogenic differentiation of PDLSCs and inhibits the development of periodontitisLIU et al. [85], 2023miR-181d-5pPDLSCsInhibits tumor necrosis factor (TNF)Promotes effect on osteogenic differentiationQU et al. [86], 2024miR-935SCAPsMay target include STAT1 and HMGB1Alleviates oral inflammatory bone lossZHANG et al. [87], 2022miR-31-5pPDLSCsTargets eNOS associated with osteoclastogenesisRegulates alveolar bone regenerationLU et al. [88], 2023miR-378aDPSCsDownregulates Sufu to activate the Hedgehog/Gli1 signalling pathwayPromotes endothelial cells (ECs) angiogenesisZHOU et al. [89], 2021miR-125aADSCsDirectly repressed the expression of DLL4Enhances endothelial cell tube-like structure formationZHANG et al. [90], 2016miR-423-5pADSCsPlays a role in post-transcriptional regulation of miR-423-5p on Sufu geneRegulates angiogenesisXU et al. [91], 2019miR-1260bGMSCsTargets Wnt5a-mediated RANKL pathwayRegulates inflammation and osteoclastogenesisNAKAO et al. [78], 2021miR-1246MSCsSuppresses the expression of Nfat5Mediates immunomodulationZHANG et al. [92], 2021miR-590-3pPDLSCsSuppresses TLR4 transcriptionReduces macrophagepyroptosis andalleviating periodontalinflammatory injuryHAN et al. [93], 2022miR-1246DPSCsFacilitates conversion of macrophage inflammatory phenotypeMediates the effects of DPSC-Exo in treating periodontitisSHEN et al. [94], 2022miR-143-3pPDLSCsRegulates PI3K/AKT/NF-κB signalingFacilitates M1 macrophage polarizationWANG et al. [95], 2023miR-155-5pPDLSCsTargets Sirtuin-1 (SIRT1)Alleviates inflammatory microenvironment through regulating Th17/TregZHENG et al. [81], 2019miR-205-5pPDLSCsBinds to X-box binding protein 1 (XBP1)Relieves the inflammation and balances the Th17/Treg cellsKANG et al. [96], 2023 Table 2Specific miRNAs in MSCs-EVs with reported roles in periodontal regenerationmiRNAsEVs sourceTarget MechanismsFunctional effectsRefs. and yearmiR-22-3pBMSCsNegatively targeted FTO expressionPromotes osteogenic differentiationZHANG et al. [77], 2020miR-335-5pBMSCsDownregulates the expression of DKK1Promotes osteogenic differentiation of PDLSCs and inhibits the development of periodontitisLIU et al. [85], 2023miR-181d-5pPDLSCsInhibits tumor necrosis factor (TNF)Promotes effect on osteogenic differentiationQU et al. [86], 2024miR-935SCAPsMay target include STAT1 and HMGB1Alleviates oral inflammatory bone lossZHANG et al. [87], 2022miR-31-5pPDLSCsTargets eNOS associated with osteoclastogenesisRegulates alveolar bone regenerationLU et al. [88], 2023miR-378aDPSCsDownregulates Sufu to activate the Hedgehog/Gli1 signalling pathwayPromotes endothelial cells (ECs) angiogenesisZHOU et al. [89], 2021miR-125aADSCsDirectly repressed the expression of DLL4Enhances endothelial cell tube-like structure formationZHANG et al. [90], 2016miR-423-5pADSCsPlays a role in post-transcriptional regulation of miR-423-5p on Sufu geneRegulates angiogenesisXU et al. [91], 2019miR-1260bGMSCsTargets Wnt5a-mediated RANKL pathwayRegulates inflammation and osteoclastogenesisNAKAO et al. [78], 2021miR-1246MSCsSuppresses the expression of Nfat5Mediates immunomodulationZHANG et al. [92], 2021miR-590-3pPDLSCsSuppresses TLR4 transcriptionReduces macrophagepyroptosis andalleviating periodontalinflammatory injuryHAN et al. [93], 2022miR-1246DPSCsFacilitates conversion of macrophage inflammatory phenotypeMediates the effects of DPSC-Exo in treating periodontitisSHEN et al. [94], 2022miR-143-3pPDLSCsRegulates PI3K/AKT/NF-κB signalingFacilitates M1 macrophage polarizationWANG et al. [95], 2023miR-155-5pPDLSCsTargets Sirtuin-1 (SIRT1)Alleviates inflammatory microenvironment through regulating Th17/TregZHENG et al. [81], 2019miR-205-5pPDLSCsBinds to X-box binding protein 1 (XBP1)Relieves the inflammation and balances the Th17/Treg cellsKANG et al. [96], 2023 Specific miRNAs in MSCs-EVs with reported roles in periodontal regeneration Reduces macrophage pyroptosis and alleviating periodontal inflammatory injury MiR-22-3p from BMSCs-derived EVs has been reported to be associated with osteogenic differentiation, which negatively targets fat mass and obesity-associated proteins (FTO). FTO influences adipogenesis and osteogenesis of stem cell [76]. Repressing the expression of FTO, which reduces MYC mRNA stability and suppresses the MYC pathway, which interacts with PI3K activation, resulting in inhibition of the PI3K/AKT pathway to enhance osteogenic differentiation with increased ALP activity and expression of genes related to mineralization [77]. Following tumor necrosis factor (TNF-α) stimulation, exosomes from human gingival mesenchymal stem cells (GMSCs) play a crucial role in preventing alveolar bone loss and are now attributed to TNFα-inducible exosomal miR-1260b. Research indicates that miR-1260b binds to transcription factor (ATF)-6β, which regulates osteoclastogenesis under endoplasmic reticulum (ER) stress, inhibits RANKL expression, and prevents periodontal bone loss [21]. Moreover, miR-1260b in TNF-α-induced exosomes is suggested to drive macrophage polarization towards the M2 phenotype, alleviate inflammation, and enhance periodontal tissue repair and regeneration in mice [78]. The regenerative properties of exosomes derived from PDLSCs are likely due to variations in miRNA expression profiles of PDLSCs-EVs [79]. In exosomes from PDLSCs in osteogenesis, and 72 miRNAs were upregulated and 35 were downregulated compared to those from undifferentiated PDLSCs. The sequencing results revealed that miR-122-5p, miR-142-5p, miR-25-3p, and miR-192-5p were notably upregulated in exosomes from PDLSCs during osteogenic differentiation. These miRNAs act as osteogenic regulators, enhancing osteogenesis-related signaling pathways and promoting periodontal bone regeneration by regulating their downstream target genes and pathways [80]. MiR-155-5p is critical for regulating the differentiation and homeostasis of T-helper 17 (Th17) and regulatory T (Treg) cells. Exosomes isolated from normal PDLSCs exhibit decreased miR-155-5p expression compared to those isolated from periodontal stem cells stimulated with LPS, which induces and imitates a localized inflammatory microenvironment. Inhibition of miR-155-5p results in a decrease in Treg levels, an increase in Th17 levels, and reduced inflammation. Sirtuin-1 (SIRT1) is a direct target of miR-155‐5p. Thus, lowering miR-155-5p expression can diminish inflammation and prevent the progression of periodontitis through the Th17/Treg/miRNA-155-5p/ /SIRT1 signaling pathway [81]. This evidence indicates that MSCs-derived exosomal miRNAs are valuable signaling molecules that can contribute to strengthening the significance of the role of exosomes. Because the link between miRNA profiles in exosomes and periodontitis is very strong, exosomal miRNA expression is under investigation as a biomarker for periodontal regeneration. Mechanisms of mesenchymal stem cell-derived miRNAs in periodontal tissue regeneration Several studies have indicated that the therapeutic effects of stem cells are partly derived from the presence of miRNAs [82, 83]. The discovery of stem cell-derived miRNAs can be seen as a brand-new lantern that sheds light on novel therapeutic approaches for periodontal regeneration. Therefore, more insight into the underlying mechanisms of these therapies is needed to enhance the efficacy of the established miRNAs-based therapies. Recently, several studies have been conducted on the underlying mechanisms (Fig. 3), which are specifically explained below (Tables 1 and 2). Regulating bone formation of periodontal tissues In recent years, advances in bone tissue engineering have offered new hope for the repair and regeneration of alveolar bones in patients with periodontitis. Analysis of MSCs properties that contribute to the enhancement of osteogenesis reiterates the importance of miRNAs [84]. A recent study reported that significant differences in miRNA expression profiles are key mechanisms regulating osteogenic differentiation [13] (Fig. 5). Fig. 5Schematic illustration of periodontitis treatment by altering MSCs-derived miRNA expression level to contribute to the improvement of stem cell therapy. (All images are reproduced with permission from Zhang et al. [13]) Schematic illustration of periodontitis treatment by altering MSCs-derived miRNA expression level to contribute to the improvement of stem cell therapy. (All images are reproduced with permission from Zhang et al. [13]) The expression of miR-26a is significantly increased in both BMSCs and ADSCs during osteogenic induction [97], but shows a completely opposite effect on osteogenic differentiation. Overexpression of miR-26a strengthened the osteogenic differentiation of BMSCs, whereas osteogenesis was significantly inhibited in the ADSCs. This phenomenon is most likely due to miR-26a depending on Wnt and BMP signaling to show different functions in different types of cells [98]. Thus, the involvement of miR-26a-enriched BMSCs can be used to significantly promote osteogenesis in periodontal tissues [99]. Additionally, numerous studies on miRNAs have demonstrated that specific miRNA that can be selectively packaged into EVs negatively modulate osteogenesis in proximal or distal cells. MiR-765 decreases in hMSCs during osteogenic differentiation. Overexpression of miR-765 downregulates osteogenesis-related genes, ALP activity, and matrix mineralization. MiR-765 acts to negatively regulates osteogenic differentiation of hMSCs by directly binding to BMP6, which is associated with bone formation. BMP6 ultimately activates Smad1/5/9. This suggests that the BMP6/Smad1/5/9 pathway is likely to be a key regulatory mechanism in the context of hMSC osteogenic differentiation [100]. It is discovered that 13 miRNAs promoted and 17 suppressed odontogenic/osteogenic differentiation: hsa-miR-140-5p, hsa-miR-218 and hsa-miR-143 were the most intensely reported miRNAs which restrain the proliferation and osteoblastic differentiation of Human dental pulp-derived mesenchymal stem cells (hDP-MSCs). This miRNA group is critical for osteoblast differentiation and regulates progression of the osteogenic spectrum [101]. Promoting the angiogenesis of MSCs Periodontitis is invariably associated with abnormal angiogenesis which can sustain or strengthen inflammation [102]. The alveolar bone is highly vascularized which can provide essential nutrients and factors through intraosseous blood vessels for the microenvironment in periodontal regeneration [103]. Consequently, the angiogenesis of MSCs at an injury site is an indispensable step in periodontal regeneration. MSCs release exosomes that transfer miRNAs to their receptor cells and promote angiogenesis. Zhou et al. found that extracellular vesicles from periodontitis-compromised dental pulp stem cells (P‐EVs) present considerable advantages over healthy substitutes in promoting cell proliferation, migration, and angiogenesis in periodontal regeneration, which may be due to the differential expression of miRNAs between P‐EVs and healthy dental pulp stem cells (H‐EVs), such as miR-378a. A luciferase assay reported that the suppressor of fused (Sufu) is the target gene of miR-378a, which promotes angiogenesis and increases Gli1 expression in endothelial cells (ECs). They concluded that P-EVs-mediated transmission of miR-378a enhanced vessel regenerative potential by targeting Sufu to activate Hedgehog/Gli1 signaling [89]. In addition, miR-125a enriched in exosomes secreted by human adipose-derived MSCs (adMSCs-Exo) is involved in enhancing endothelial cell tube-like structure formation in vitro and in vivo. When adMSCs-Exos loaded with miR-125a were transferred to HUVECs, the expression levels of proangiogenic genes (Ang1 and Flk1) were significantly upregulated. Liang et al. confirmed that miR-125a directly repressed the expression DLL4 which is associated with anti-angiogenesis [82]. Reducing inflammation in periodontal tissues The control of inflammation is a prerequisite for periodontal tissue regeneration. In recent years, miRNAs that alleviate inflammation have received extensive attention [104]. Significant differences in miRNA expression profiles between MSCs originating from inflamed and non-in flamed tissues are key to controlling the balance between pro-inflammatory and later immunoregulatory and anti-inflammatory responses in the periodontal microenvironment. MiR-212-5p was identified to be downregulated in Porphyromonas gingivalis LPS-treated PDLSCs groups compared to that in the control group. At the cellular level, overexpression of miR-212-5p promoted cell viability and elevated pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6, thereby reducing the inflammatory response. Myd88 is the downstream target of miR-212-5p, which may involve the inactivation of p38 MAPK and nuclear factor kappa-B [64]. The recent study found that the expression levels of miRNA-671-5p in hPDLSCs increased after treatment with LPS. In contrast to miR-212-5p, upregulated miR-671-5p exhibits proinflammatory characteristics and suppresses proliferation via the DUSP8/p38 MAPK pathway [67]. Host immune reactions play a pivotal role in the onset of periodontitis [105]. Numerous basic and clinical data indicate that the immunomodulatory properties of MSCs are particularly beneficial for damaged tissues [106]. MiRNAs have recently emerged as critical regulators of the immune response based on effect on immune cell [107]. Macrophages (Mø), are one of the most critical immune cells, including the pro-inflammatory phenotype (M1) and the anti-inflammatory phenotype (M2), The conversion of macrophage phenotype in regeneration and their response to LPS is finely regulated by miRNA networks [108, 109]. Li et al. demonstrated that specific miRNAs such as miR-143-3p in exosomes from PDLSCs in an inflammatory environment could modulate the functional polarization of macrophages, which may aggravate periodontal inflammation. Related experiments revealed that inflammatory PDLSCs-derived exosomal miR-143-5p promoted pro-inflammatory M1 macrophage polarization and aggravated periodontal inflammation by suppressing PI3K/AKT signaling and activating NF-κB signaling [95]. Cui et al. also incubated macrophages with exosomes from LPS-treated PDLSCs to monitor the expression profiles of inflammatory and anti-inflammatory cytokines and polarization markers. They concluded that LPS mediates macrophage polarization to the M1 state through the TLR2/TLR4/NF-κB p65 signaling pathway, partially mediated by exosomal miR-433-3p in LPS-treated PDLSCs, which could contribute to the repression of periodontitis [79]. Additionally, miRNAs regulate the balance between Th17 and Treg cells [110], which is vital for maintaining immune homeostasis. This balance is often disrupted in the peripheral blood of periodontitis patients, and miRNAs participate in this process [111]. Taken together, MSCs-derived miRNAs are involved in regulating the inflammatory response in periodontal tissues through a variety of mechanisms, such as inhibiting the expression of inflammatory factors, promoting the release of anti-inflammatory factors, regulating immune cell function, and modulating inflammation-related signaling pathways. These regulatory effects help reduce the level of inflammation and promote the health and regeneration of periodontal tissues, thereby providing new ideas and strategies for the treatment and prevention of periodontitis. Regulating the process of autophagy and apoptosis Autophagy is a conserved and indispensable cellular activity involved in the regeneration of wounded tissues, which provides nutrients and discards useless cellular macromolecules [112]. Interestingly, the modulation of autophagy in MSCs may affect their stemness and support the restoration of damaged tissues and organs [113]. Recent studies suggest that the regulation of autophagy and apoptosis by MSCs-derived miRNAs may also affect disease development and treatment response: Yang et al. confirmed that miRNA-let-7a is highly expressed in MSCs and activates autophagy by regulating the signaling pathways associated with autophagy, resulting in osteogenesis [114]. Therefore, the viability and regenerative potential of stem cells and contributing to the rapid repair of periodontal tissues by miRNAs in regulating autophagy. In addition, miRNAs also regulate apoptosis, a form of programmed cell death, may be triggered by common upstream signals [115]. Li et al. found that the overexpression of miRNA-543-3p in LPS-treated PDLSCs, increasing the expression of Bcl-2, while decreasing the expression of Bax, cleaved caspase-3, and cleaved caspase-9 resulting in activating the proliferation and preventing apoptosis of LPS-treated PDLSCs. The downstream target of miR-543-3p is KLF6, which plays a critical role in apoptosis and other life activities [20]. In summary, miRNAs from stem cells can not only directly affect the regenerative process of periodontal tissues by regulating mechanisms such as autophagy and apoptosis but also improve the predictability and durability of therapeutic effects. Although further studies and clinical trials are needed to verify their specific effects and safety, these regulatory effects provide potentially important strategies for personalized and efficient periodontal tissue regeneration therapies in the future. Clinical translation and application of mesenchymal stem cell-derived miRNAs Based on the above findings, MSCs-derived miRNAs have been processed to facilitate in vitro validation [116]. Currently, there is existing great practical difficulties:1) MiRNA functions maybe conflict with loss-of-function models due to unduplicated microenvironment of periodontal tissues; 2) Unintended impacts on non-targeted cells and tissues [117]; 3) Necessary dosage, proper administration techniques and the design of miRNA-based drugs and delivery system; 4) consistent and sustainable rates of cellular uptake [118]; 5) The risk of incompatibilities and side-effects between the vehicles and miRNAs [119]. To promote their clinic application, several efforts have been made to modifying and reversing the expression of miRNAs in injured tissue [120], conjugate miRNAs with other biomolecules and develop delivery systems for the further application of miRNAs [121, 122] (Fig. 6). Fig. 6Innovative approaches in transforming miRNAs in therapy methods. MiRNA agents such as miRNAs mimics and miRNA antagomir through replacing or inhibiting specific miRNA function which may correct miRNA deficiencies and aberrantly expression in periodontal tissues. Several approaches have been established to delivery therapeutic miRNAs into damage tissues to achieve periodontal regeneration Innovative approaches in transforming miRNAs in therapy methods. MiRNA agents such as miRNAs mimics and miRNA antagomir through replacing or inhibiting specific miRNA function which may correct miRNA deficiencies and aberrantly expression in periodontal tissues. Several approaches have been established to delivery therapeutic miRNAs into damage tissues to achieve periodontal regeneration Given the ability of miRNAs enriched in specific cells to target specific mRNAs, mimics or inhibitors of miRNAs can be used prospectively in the form of antagomirs or antimirs to reverse levels of miRNAs and ultimately realize tissue regeneration [123, 124]. Antagomirs (miRNA mimics) are synthetic short double-stranded oligonucleotides, act as the compensation of down-regulated endogenous miRNAs to keep down of aberrant expression of some protein in aberrant conditions [125]. Antimirs(anti-miRNAs) which mainly based on first-generation antisense single-stranded oligonucleotides (ASOs), or chemically modified to improve their properties, are used to mediate degradation or functional blocking of endogenous miRNAs up to enhance repairment and regeneration [119]. Some scholars directly injected antagomirs or antimirs into animal models of periodontal infection, which facilitates the development of periodontal regeneration [126]: Shen et al. found that miR-1246 which accounts for most of the miRNA expression profiles in dental pulp stem cells derived extracellular vesicles (DPSCs-EVs). They used antagomir-1246 leading to alleviated the severity of periodontitis progression and facilitated the conversion of macrophages to an anti-inflammatory phenotype in the periodontium of mice with periodontitis [94]. Furthermore, Zhang et al. further confirmed that miR-1246 enriched in exosomes derived from three-dimensional (3D)-cultured MSCs contributing to restore the Th17 cell/Treg balance fewer osteoclasts and infiltrated inflammatory cells within periodontium when treated ligature-induced periodontitis mice with the miR-1246 antagomir [92]. In vivo local injection of MSCs-miRNAs into sites of periodontitis in rats exhibit promising therapeutic effects for precision treatment in periodontitis. Hydrogels are prominent candidates for tissue engineering because of their biocompatibility, plasticity, and distinct biological functions, which provide a favorable environment [127]. Injectable the local and continuous delivery of synthetic miRNAs to specific cells and tissues. It has been shown that the amphiphilic cell-penetrating peptide RALA can efficiently deliver miR-26a to MSCs in vitro, thereby influencing osteogenic signaling. In vivo, the application of RALA/miR-26a NPs via an injectable thermo-responsive Cs-g-PNIPAAm hydrogel has also demonstrated angiogenesis and mechanical properties [99]. Liu et al. developed controlled-release systems for miR-10a which enhances T-cell differentiation into Tregs to facilitate the sustained delivery of miR-10a [128]. Efficient delivery of microRNAs conjugated with carrier materials in periodontal tissues is a very promising field [129]. Even though preclinical studies have demonstrated the effects of MSCs-miRNAs in periodontal regeneration, their clinical trials for periodontitis treatment are still in its infancy. Several clinical trials have been registered on “www.clinicaltrials.gov”: the investigators mostly observed the expression of miRNAs in gingival crevicular fluid associated with periodontitis and intervene methods such as miRNA 7a-5p, miRNA 21-3p, miRNA 21-5p, miRNA 200b-3p, miRNA 200b-5p, miRNA 100-5p, miRNA 125-5p levels (NCT05383794, Italy) (NCT05275127, Italy) (NCT03510702, Spain). Furthermore, the specific details and progress have not been updated. Recently, several studies have updated patents for therapeutic miRNAs in periodontitis, providing an easy-to-use and effective strategy for miRNA modification. Patent CN202311724273.6 demonstrates that miRNA-141-5p can serve as a potential target for the treatment of periodontitis by regulating the expression of disease-related chemokines, such as CXC chemokine receptor 1, interleukin 8, and proplatelet basic protein. In vivo experiments showed that miR-141-5p mimics have a regulatory effect on periodontitis in mice. Yang et al. (CN202110697597.X) found that Let-7a could regulate the osteogenic differentiation of periodontal ligament stem cells, combined with aggregates of these cells, to form a system for repairing periodontal defects, offering a viable method for the rapid and effective repair of these defects. Zhao et al. (CN201610831694.2) developed an injectable miRNA-activated hydrogel that promotes alveolar bone healing in dental implants by encapsulating miRNAs in a nano-microcapsule formed from a copolymer of N-(3-aminopropyl) methacrylamide, acrylamide, and ethylene glycol dimethacrylate. This capsule, when mixed with carboxymethyl chitosan and bone powder, not only improves osteogenic quality, but also reduces the time required for alveolar bone osteogenesis and provides space for bone tissue growth. Despite the therapeutic potential of miRNAs derived from MSCs, numerous practical suggestions remain concerning the clinical application, such as the need to refine isolation techniques, optimize culture conditions, and develop extraction methods that influence regenerative capabilities. There is also a need to determine the appropriate dosage and frequency of administration, maintain in vivo stability to prevent degradation, target specific tissues and cell types, and achieve the desired intracellular effect [130, 131]. Additionally, designing personalized miRNA therapy protocols based on patient-specific conditions (e.g., degree of inflammation, size of bone defects, etc.) is worthy of being taking into account. We also can conduct small-scale clinical trials on MSCs-miRNAs to evaluate the safety and efficacy of miRNAs in periodontal regeneration and provide data support for subsequent large-scale trials. Overall, miRNAs have significant potential in periodontal clinical applications and are crucial for disease diagnosis, treatment, and prognostic assessment. With ongoing research on the biological functions of MSCs-derived miRNAs and continuous technological advancements, miRNAs are expected to become vital tools and targets in clinical medicine. Conclusion and prospects Accumulating evidence suggests that the therapeutic value of MSCs is mainly attributable to miRNAs existing as intracellular and exosomal [22]. MSCs and MSCs-EVs contain the enrichment of periodontal repair-favorable miRNAs, being able to possess anti-apoptotic, anti-inflammatory, osteogenesis, and angiogenic effects within the injured tissues [116, 132]. Furthermore, the role of MSCs-miRNAs such as miR-1246, miR-1260b and miR-378a, which have shown preclinical promise in animal periodontitis models which are most likely to enter clinical trials soon [133].These trials are still in initial stage, a host of experiments focus on observing the expression of miRNAs in gingival crevicular fluid (Table 3). As such, it is awaited to see the safety and effectiveness of these miRNA therapeutics perform in human clinical trials. Table 3Clinical trials of miRNAs in periodontitisStudy TitleNCT NumberStatusConditionsInterventionsRole of miRNAs in CVD and PeriodontitisNCT05383794CompletedCardiovascular DiseasesPeriodontal DiseasesObservation of Evaluation of the miRNA expression of gingival crevicular fluidImpact of Periodontal Treatment on Local miRNA ExpressionNCT05275127CompletedCardiovascular DiseasesPeriodontal Diseaseschanges of gingival crevicular fluid miRNAQuantification of Micro-RNA 146-a in Chronic Periodontitis and Coronary Heart Disease SubjectsNCT03721159CompletedPeriodontal DiseasesCoronary DiseaseSCREENING OF EPIGENETIC BIOMARKERS (miRNAs) IN THE GINGIVAL SULCUSNCT03510702Unknown statusPeriodontal DiseasesInflammatory ResponseLevels of epigenetic biomarkers present in the gingival fluid and its possible relationship with bone metabolism.miRNAs in Periodontal DiseaseNCT05046678CompletedPeriodontal DiseasesPeriodontitisGingivitisDiagnostic Test: ControlDiagnostic Test: Smokers with periodontally healthyDiagnostic Test: Non-smokers withgingivitis3 moreGCF miRNA-223, -214 Levels in Smokers and Nonsmokers Periodontitis PatientsNCT06064799CompletedPeriodontitis, AdultmiRNA-223 & -214 detectionmicroRNA 155 Levels and Periodontal Microflora (Bacteria and Virus) in Preeclampsia.NCT04277390CompletedPreeclampsiaChronic Periodontitisclinical intervention for microbial analysis and miR-155 as biomarkerInterplay of miRNA-146a and miRNA-126 in Chronic Periodontitis Patients With Coronary Artery DiseaseNCT04583085CompletedChronic PeriodontitisCoronary Artery DiseasemiRNA Table 3Clinical trials of miRNAs in periodontitisStudy TitleNCT NumberStatusConditionsInterventionsRole of miRNAs in CVD and PeriodontitisNCT05383794CompletedCardiovascular DiseasesPeriodontal DiseasesObservation of Evaluation of the miRNA expression of gingival crevicular fluidImpact of Periodontal Treatment on Local miRNA ExpressionNCT05275127CompletedCardiovascular DiseasesPeriodontal Diseaseschanges of gingival crevicular fluid miRNAQuantification of Micro-RNA 146-a in Chronic Periodontitis and Coronary Heart Disease SubjectsNCT03721159CompletedPeriodontal DiseasesCoronary DiseaseSCREENING OF EPIGENETIC BIOMARKERS (miRNAs) IN THE GINGIVAL SULCUSNCT03510702Unknown statusPeriodontal DiseasesInflammatory ResponseLevels of epigenetic biomarkers present in the gingival fluid and its possible relationship with bone metabolism.miRNAs in Periodontal DiseaseNCT05046678CompletedPeriodontal DiseasesPeriodontitisGingivitisDiagnostic Test: ControlDiagnostic Test: Smokers with periodontally healthyDiagnostic Test: Non-smokers withgingivitis3 moreGCF miRNA-223, -214 Levels in Smokers and Nonsmokers Periodontitis PatientsNCT06064799CompletedPeriodontitis, AdultmiRNA-223 & -214 detectionmicroRNA 155 Levels and Periodontal Microflora (Bacteria and Virus) in Preeclampsia.NCT04277390CompletedPreeclampsiaChronic Periodontitisclinical intervention for microbial analysis and miR-155 as biomarkerInterplay of miRNA-146a and miRNA-126 in Chronic Periodontitis Patients With Coronary Artery DiseaseNCT04583085CompletedChronic PeriodontitisCoronary Artery DiseasemiRNA Clinical trials of miRNAs in periodontitis Cardiovascular Diseases Periodontal Diseases Cardiovascular Diseases Periodontal Diseases Periodontal Diseases Coronary Disease Periodontal Diseases Inflammatory Response Periodontal Diseases Periodontitis Gingivitis Diagnostic Test: Control Diagnostic Test: Smokers with periodontally healthy Diagnostic Test: Non-smokers with gingivitis 3 more Preeclampsia Chronic Periodontitis Chronic Periodontitis Coronary Artery Disease miRNA This review lists only a small fraction of miRNAs from MSCs involved in periodontal regeneration; it is likely that these small but powerful molecules associated with periodontal regeneration will only increase. The exploration of miRNAs enhances our understanding of the mechanisms of intracellular information response and intercellular transfer and opens potential opportunities for their application in tissue engineering, regenerative medicine, and disease treatment.